| mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.9 |
| mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |